Key result
The 2017 AAP guidelines update pediatric hypertension protocols to prevent CV and renal morbidity.
Why the study?
Pediatric hypertension prevalence has risen to 16.3%, and untreated hypertension in children leads to significant adult cardiovascular and renal morbidity, motivating updated guidelines.
This review of the 2017 AAP guidelines aims to familiarize clinicians with updated protocols for screening and managing pediatric hypertension to prevent long-term cardiovascular and renal morbidity.
Pediatric hypertension has risen to an overall prevalence of 16.3%. If left untreated, hypertension in children and adolescents can have significant implications for cardiovascular and renal health into adulthood, including stroke, coronary artery disease, kidney disease, and heart failure. In 2017, the American Academy of Pediatrics (AAP) released updated guidelines for the screening, evaluation, and management of pediatric hypertension. This article reviews the definition of pediatric hypertension, describes why the guidelines were updated, and defines treatment protocol. By familiarizing themselves with and applying these guidelines, clinicians will be able to appropriately screen and manage hypertension in children to prevent morbidity into adulthood.
No takes yet. Share an insight, caveat, or question.
Garvick et al. (2020) conducted a review in Pediatric hypertension. 2017 AAP guidelines for screening, evaluation, and management of pediatric hypertension was evaluated. The 2017 American Academy of Pediatrics guidelines provide updated protocols for the screening, evaluation, and management of pediatric hypertension to prevent cardiovascular and renal morbidity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: